Molecular diffusion/cerebrospinal fluid flow theory;Teoría de la difusión molecular/flujo del líquido cefalorraquídeo

Revista de Neurologia

Volumn 39, Issue 6, 2004, Pages 564-569

  Dorta Contreras, Alberto Juan ^a,c   Reiber, H ^b  

^a INSTITUTO SUPERIOR DE CIENCIAS MÉDICAS DE LA HABANA   (Cuba)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Laboratorio Central de Líquido Cefalorraquídeo   (Cuba)

Author keywords

Brain CSF barrier; Cerebrospinal fluid; Diffusion; Hyperbolic function; Immunoglobulins; Neurological disorders; Permeability; Sensibility

Indexed keywords

ALBUMIN; PROTEIN; ALBUMINOID;

BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID FLOW; DIFFUSION; FLOW MEASUREMENT; HUMAN; MOLECULAR DIFFUSION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PERMEABILITY; PROTEIN TRANSPORT; REVIEW; THEORY; BIOLOGICAL MODEL; BIOPHYSICS; BLOOD BRAIN BARRIER; BODY FLUID COMPARTMENT; CAUDA EQUINA; CEREBROSPINAL FLUID; HISTOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL;

ALBUMINS; BIOPHYSICS; BLOOD-BRAIN BARRIER; BODY FLUID COMPARTMENTS; CAUDA EQUINA; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PROTEINS; DIFFUSION; HUMANS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; PERMEABILITY;

EID: 8144222946     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3906.2004159     Document Type: Review

References (30)

1. Tourtellotte WW. On cerebrospinal fluid immunoglobulin G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesis per day by the central nervous system. J Neurol Sci 1970; 10: 279-304.
2. Link H, Tibbling G. Principles of albumin and IgG disorders. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397-401.
3. Reiber H. The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of CSF. J Neurol 1980; 224: 89-99.
4. Reiber H. Evaluation of blood-cerebrospinal fluid barrier dysfunction in neurological diseases. In Suckling AJ, Rumsby MG, Bradbury MWB, eds. The blood-brain barrier in health and disease. Chichester: Ellis Horwood; 1986. p. 147-57.
5. Ohman S, Ernerud J, Forsberg H, von Schenck H, Vrethem M. Improved formulae for the judgment of the intrathecally produced IgA and IgM in the presence of blood-CSF barrier damage. Ann Clin Biochem 1993; 30: 454-62.
6. Laurel CB. On the origin of major CSF proteins. In Thompson ET, ed. Advances in CSF protein research and diagnosis. Lancaster, UK: MTP Press; 1987. p. 123-8.
7. Reiber H, Felgenhauer K. Protein transfer at the blood-CSF barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987; 163: 319-28.
8. Reiber H. Flow rate of cerebrospinal fluid (CSF) -a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994; 122: 189-203.
9. Felgenhauer K. Protein size and cerebrospinal fluid composition. Klin Wschr 1974; 52: 1158-64.
10. Rappoport SI. Passage of proteins from blood to cerebrospinal fluid. In Wood JH, ed. Neurobiology of cerebrospinal fluid. Vol 2. New York: Plenum; 1983. p. 233-45.
11. Davson H, Welch K, Segal MB. Physiology and pathophysiology of the cerebrospinal fluid. London: Churchill; 1987. p. 53-78.
12. Reiber H. Proteins in cerebrospinal fluid and blood. Barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 2003; 21: 79-96.
13. Bradbury M. The concept of a blood-brain barrier. Chichester: Willey & Sons; 1979. p. 1-305.
14. Felgenhauer K, Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpesvirus induced diseases if the nervous system. Clin Investig 1992; 70: 28-77.
15. Dorta-Contreras A. Reibergramas: elemento esencial en el análisis inmunológico del líquido cefalorraquídeo. Rev Neurol 1999; 28: 996-8.
16. Lejon V, Reiber H, Legros D, Dje N, Magnus E, Wouters I, et al. Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. Infect Dis 2003; 187: 1475-83.
17. Reiber H, Thompson EJ, Grimsley G, Bernardi G, Adam P, Monteirode Almeida S, et al. Quality assurance for cerebrospinal fluid protein analysis: international consensus by an Internet-based group discussion. Clin Chem Lab Med 2003; 41: 331-7.
18. Dorta-Contreras AJ, Reiber H, Magraner-Tarrau ME, Weissbrick B, Interian-Morales MT, Noris-García E, et al. Valor neuroinmunoepidemiológico del reibergrama en la primera epidemia de meningoencefalitis por echovirus 16 en Cuba. Rev Neurol 2002; 35: 517-20.
19. Statz A, Felgenhauer K. Development of blood-CSF barrier. Dev Med Child Neurol 1983; 25: 152-61.
20. Mollgaard K, Saunders NR. The development of the human blood-brain and blood-CSF barriers. Neuropath Appl Neurobiol 1986; 12: 337-58.
21. Rostasy K, Reiber H, Pohl D, Lange P, Ohlenbusch A, Eiffert H, et al. Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies. Neurology 2003; 61: 125-8.
22. Dorta-Contreras AJ. Reibergrama como herramienta epidemiologica: un nuevo enfoque. Rev Neurol 2001; 33: 36-40.
23. Upton M, Weller RO. The morphology of cerebrospinal fluid drainage pathway in human arachnoid granulations J Neurosurg 1985; 63: 867-75.
24. May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI. Cerebrospinal production is reduced in healthy aging. Neurology 1990; 40: 500-3.
25. Price RA, Johnson WW. The central nervous system in childhood leukemia I. The arachnoid. Cancer 1973; 31: 520-33.
26. Yamoshima T. Functional ultrastructure of cerebrospinal fluid drainage channels in human arachnoid villi. J Neurosurg 1988; 22: 633-41.
27. Hill NC, Goldstein NP, McKanzie BF, McGuchin WF, Sviers HJ. Cerebrospinal fuid proteins glycoproteins and lipoproteins in obstructive lesions of the central nervous system. Brain 1959; 82: 581-93.
28. Reiber H, Ruff M, Uhr M. Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clin Chim Acta 1993; 217: 163-73.
29. Sucking AJ, Reiber H, Rumsby MG. The blood-CSF barrier in chronic relapsing experimental allergic encephalomyelitis. In Suckling AJ, Rumsby MG, Bradbury MWB, eds. The blood-brain barrier in health and disease. Chichester: Ellis Horwood; 1986. p. 147-57.
30. Reiber H, Thiele P. Species-dependent variables in blood cerebrospinal fluid barrier function for proteins. J Clin Chem Clin Biochem 1983; 21: 199-202.